Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Alendrex
Active Ingredient: Alendronate sodium trihydrate 52.21mg equivalent to 40mg alendronate
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Salcette, Goa, India
Product: Habitrol
Active Ingredient: Nicotine tartrate 3.072mg equivalent to nicotine base 1.0mg
Dosage Form: Lozenge
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Sanico NV, Turnhout, Belgium
SwissCo Services AG, Sisseln, Switzerland
Product: Habitrol
Active Ingredient: Nicotine tartrate 6.144mg equivalent to nicotine base 2.0mg
Dosage Form: Lozenge
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Sanico NV, Turnhout, Belgium
SwissCo Services AG, Sisseln, Switzerland
Dated this 21st day of July 2008.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).